Launching of Plureon Placental Stem Cells in India發射plureon胎盤幹細胞在印度
LifeCell, the Chennai based cord blood banking major, is all set to launch Plureon Placental stem cells from placental tissues as a new source for stem cells in India for the first time. lifecell ，奈基於臍帶血銀行的重大，是所有設置為發射plureon胎盤幹細胞從胎盤組織作為一個新的來源，幹細胞在印度為第一次。
LifeCell will be launching this in India in collaboration with Cryo-Cell International Inc. The Cryo-Cell has launched the Plureon Service three months before in the US and LifeCell expects to introduce the service in India by March 2007, informed S Abhayakumar, vice chairman, LifeCell to Pharmabiz. lifecell將推出，這在印度的合作與冷凍細胞國際公司的冷凍細胞已推出plureon服務前3個月，在美國和lifecell預計推出服務，印度在2007年3月，知情s abhayakumar ，副委員長， lifecell ，以pharmabiz 。
Plureon cells, a novel type of placental stem cells, is usually discarded as medical waste and has recently been discovered to be a rich source of unique, pluripotent stem cells under the research of Cryo-Cell. plureon細胞，一種新型的胎盤幹細胞，通常是被丟棄的醫療廢物，並於最近被發現是一個豐富的資源，獨特的，多幹細胞的研究下，冷凍細胞。 These placental stem cells are highly proliferate and have the ability to easily become bone, nerve, muscle, fat, pancreatic, and liver cells.這些胎盤幹細胞具有高度增殖，並有能力很容易成為骨，神經，肌肉，脂肪，胰腺，肝細胞。 The stem cells from this type is expected to be useful in future treatment of chronic diseases such as diabetes, heart disease, and liver disease, according to the company sources.幹細胞從這個類型，預計可在未來有用的治療慢性疾病，如糖尿病，心髒病，肝病，據該公司的來源。
Plureon cells, a specific type of stem cells from placental tissues, have already been found successful in animal trials to cure diabetes. plureon細胞，一個特定類型的幹細胞從胎盤組織，至今已成功發現，在動物試驗治療糖尿病。 The pancreatic cells formed by Plureon cells have produced functional insulin-secreting tissue in animal models, as the result of the trials.胰腺細胞所形成的plureon細胞產生功能性胰島素分泌組織在動物模型中，作為結果的審判。
